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Purpose: Chronic kidney disease (CKD) is associated with poor outcomes
in patients with acute coronary syndrome (ACS) undergoing percutaneous cor-
onary intervention (PCI).
Methods: ACS patients undergoing PCI from 2008-2009 were enrolled in
a prospective, observational registry of 11 European countries, APTOR-II.
Patients were grouped by their calculated creatinine clearance (CrCl), esti-
mated by the Cockcroft Gault equation. 2,273 patients (75%) had no or mild
renal impairment (CrCl 60 mL/min/1.73m²), 611 patients (20%) had mod-
erate to severe renal impairment (<60 mL/min/1.73m²), and 158 patients (5%)
had missing information. For patients with moderate to severe renal impair-
ment, 90% had a CrCl 30-<60, 7% had a CrCl 15-<30 and 3% had a CrCl
<15. Kaplan-Meier estimates at 12 months post-PCI were calculated for CV
event, such as stent thrombosis, bleeding and mortality.
Results: 12 months post-PCI, patients with CrCl <60 mL/min/1.73m² were
at greater risk for a CV event, bleeding, and mortality compared to patients
with CrCl 60 mL/min/1.73m².
Table – Kaplan-Meier (KM) estimate at 12 months following PCI
Conclusions: At 12 months post-PCI, ACS patients with CKD tended to
have greater rates of ischemic and bleeding events and higher mortality com-
pared to patients with no or mild renal impairment. Caution has to be exerted
with CKD patients when deciding on invasive and antiplatelet treatments.
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Objective: This study aimed to analyze the impact of diverting after hours
calls to an emergency medical dispatch centers (EMDC) on time delays and
revascularization procedures for patients with ST-segment Elevation Myocar-
dial Iinfarction (STEMI) in a French region.
Design: Prospective observational study.
Setting: All intensive care unit from one French region.
Participants: 3376 consecutive patients admitted for an acute STEMI
were included, from the RICO survey (a French regional survey for acute MI).
Patients were classified into two groups: before redirecting to EMDC (2001-
2004) and after redirecting to EMDC (2005-2008).
Main outcome measures: Thirty-days and one-year cardiovascular death.
Results: Among the 3376 patients included in the study, 1781(53%) were
admitted before redirecting to EMDC and 1595 (47%) after redirecting to EMDC.
Access to health care facilities was similar for the two groups. The rates of off-
hours calls remained stable over time. The median delay from first medical inter-
vention to hospital admission decreased from 75 (40-150) to 60 (34-110) minutes
and the delay from symptom onset to hospital admission from 170 (90-330) to 160
(90-300) minutes (p<0.001). At the same time, the off-hours median interval from
door-to-balloon dropped significantly of 54 minutes (from 152 (60-333) to 98 (45-
240) minutes (p=0.018)). Multivariate analyses showed that implementing the
EMDC significantly reduced preadmission delays even when adjusting for poten-
tial confounders. Moreover, implementing EMDC was associated with a dramat-
ical reduction of 30 days mortality by 60% in patients admitted during off hours
and undergoing primary PCI (10% vs 4%, p=0.012).
Conclusion: In a real world setting, improving the quality of prehospital
organization was effective not only on reducing delays but also on improving
access to revascularization. Although our results showed the beneficial impact
of redirecting calls on management of STEMI, it also underlines the need for
further improvements in pre-hospital transportation. 
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Aim: Early post-acute myocardial infarction pericardial effusion are the
major pericardial complications . We aimed to analyse the frequency, treat-
ments, characteristics and prognostic significance of pericardial effusion (PE)
following acute myocardial infarction.
Methods: From the French regional RICO survey database, all the patients
hospitalized between January 1st 2001 and december 31st 2009 for an acute
myocardial infarction in Côte d’Or with echocardiographic examination
(<48H) were included in the study. Data from patients with and without PE
were compared at baseline and at follow-up.
Results: 8680 patients were included in the study, of whom 135 (1.5%) were
diagnosed with PE. Patients with and without PE had similar risk factors,
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Event CrCl≥60 mL/min/1.73m² 
(N=1953)
CrCl <60 mL/min/1.73m² 
(N=754)
n at risk 
at 12 months
KM% 
(95% CI)
n at risk 
at 12 months
KM% 
(95% CI)
CV event* 1543 14.9 
(13.4, 16.3)
364 21.8 
(18.4, 25.1)
Stent thrombosis 1791 1.6 
(1.1, 2.1)
448 1.9 
(0.8, 3.0)
Bleeding 1781 2.1 
(1.5, 2.6)
435 4.7 
(3.0, 6.4)
All-cause mortality 1820 1.4 
(0.9, 1.9)
454 6.3 
(4.4, 8.3)
*CV event includes unstable angina, non-ST-elevation myocardial infarction 
(NSTEMI), STEMI, urgent target vessel revascularization, acute heart failure, 
stent thrombosis, ischemic and hemorrhagic strokes, and CV death
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including age, sex and time delays to admission. Interestingly, dyslipidemia and
history of MI was less frequent in PE group. Plasma CRP levels on admission
were markedly higher in PE patients. Prior chronic treatments were less frequent
in PE group, in particular for aspirin (11 vs 19%, p=0.027), ACE inhibitor (10 vs
18%, p=0.014) and statin (15 vs 23%, p=0.054). Acute treatments were similar,
except for BetaBlocker that were more used in patients without PE. Patients with
PE were more likely to suffer from STEMI and altered LVEF. Hospital complica-
tions such as death, or heart failure (12 vs 7%, p=0.016, 47 vs 28%, p=0.001), and
mechanical complications including atrial fibrillation, wall rupture, apical
thrombus and mitral regurgitation (respectively, 20 vs 9%, p<0.001, 7 vs 0.5%,
p<0.01, 8 vs 0.7%, p<0.01, and 8 vs 3%, p=0.03) were more frequent in PE group.
Conclusions: Our large study showed that, although PE is uncommon in
the contemporary era of acute MI, it is still associated with worse short term
prognosis, characterized by high rate of mechanical complications. Our works
also suggest a preventive effect of some CV drugs against the development of
PE following acute MI.
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Objectives: The aim of this study was to assess the prevalence and impact
on outcome of CIN occurring after primary PCI (pPCI) for STEMI, in addi-
tion to the information provided by the measure of renal function.
METHODS: In 924 consecutive STEMI patients undergoing pPCI, we mea-
sured serum creatinine concentration (CrC) and calculated creatinine clearance
(CrCl) at admission (in the cath-lab) and each day during hospitalization.
Renal impairment was defined as a CrCl <60ml/min. CIN was defined #1 –
by an increase of 25% of Cr C between the baseline and the peak (classic def-
inition) and, # 2 – by a decrease of 25% of CrCl according to the Cockroft-
Gault Formula (new definition). 
Results: Renal impairment was found in 26.1% at admission and in 29.6% of
patients after the pPCI and had a major impact on in-hospital mortality (13.8% vs.
2.25% in patients without renal dysfunction, OR 7.1; p<0.0001). The relation was
even stronger after pPCI (15.6% vs. 1.7%, OR 8.8; p<0.0001). Using definition#1,
CIN occurred in 17.2% (159) of patients and was associated with a three-fold
increase in mortality when compared with patients without CIN (11.6% vs. 3.9%,
OR 3.2, p=0.0036). The rate of CIN was 11.3% (104) with definition #2 and asso-
ciated with a four-fold increase in mortality (15.3% vs. 4.0%, OR 4.3, p=0.0005).
The combined effect on in-hospital mortality of baseline renal impairment and
CIN after pPCI is shown on figure 1.The mean volume of contrast media was sim-
ilar in patients developing CIN or not (218±44 vs. 217±50; p=0.8 definition #1;
213±39 vs. 218±49; p =0.5 definition #2) and did not relate to survival either
(219± 9 ml vs. 216± 2 ml; p=0.7).
Conclusions: In STEMI patients CIN is a major factor of in-hospital death
when it occurs in patients with basal renal impairment and seem independent
to the amount of contrast media. A new definition of CIN based on CrCl
seems more sensitive to predict mortality.
005
Impact of functional decline on outcome in elderly patients with acute
coronary syndromes
Sylvestre Maréchaux [Orateur] (1), Vincent Decourcelle (2), Claire Pincon
(3), Stéphanie Barrailler (4), Thomas Guidez (4), Sophie Braun (4), Nadia
Bouabdalloui (4), Jean-Jacques Bauchart (4), Jean-Luc Auffray (4), Phi-
lippe Asseman (4), Eric Van Belle (4), Thierry H Le Jemtel (5), Pierre-
Vladimir Ennezat (6)
(1) GHICL, faculté libre de médecine de Lille, Lomme, France – (2) CH
Armentières, Armentières, France – (3) Département de biomathéma-
tiques, Lille, France – (4) CHRU Lille, Lille, France – (5) Tulane Medical
School of Medicine, New Orleans, Etats-Unis – (6) CHRU Lille, Cardio-
logie, Lille, France
Introduction: The present study was designed to identify the mid and long
term impact of limitations of daily activities (functional decline) on outcome
in a cohort of elderly ACS patients.
Methods: Clinical data including the Global Registry of Acute Coronary
Events (GRACE) score and assessment of functional status using Katz scale
was prospectively collected in a cohort of 272 patients 70 years old admitted
for an ACS. All cause mortality was assessed at 6-month and in alive patients
after the initial 6 months of follow-up.
Results: Mean age was 78+/-6 years (men 58%). Functional decline was
diagnosed in 28% of the cohort. At 6-month follow-up 38 patients died and
during a median follow up of 611 [1-1320] days after 6-month post ACS,
29 patients died. Functional decline was associated with both 6-month and
long-term outcome (HR=3.629 [1.914-6.881], p<0.0001 and HR=2.69 (1.28-
5.64), p=0.009 respectively). Functional decline remained associated with
both 6 months and long-term outcome in multivariate analysis. Functional
decline was systematically selected in the most predictive multivariate models
for the prediction of 6-month and long-term mortality in term of global model
fit, calibration and discrimination. While the multivariate model including the
GRACE score and functional decline had a good predictive value for the pre-
diction of 6-months mortality, the combination of functional decline to biolog-
ical data (low estimated Glomerular Filtration Rate and haemoglobin) had a
better predictive value for the prediction of long-term mortality than a model
combining functional decline to the GRACE score.
Conclusions: The present study provides strong evidence that functional
decline represents a short – and long-term prognosticator in elderly ACS
patients. Functional decline should be considered to achieve coordinated care
and thereby improve outcome in elderly.
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Background: Despite the superiority of primary angioplasty in the man-
agement of ST elevation myocardial infarction (STEMI), thrombolysis
remains more frequently used worldwide particularly in developing countries.
The aim of this analysis was to identify predictors of thrombolytic therapy
success in STEMI patients.
Methods: Among 1353 patients included in our MIRAMI (MonastIR
Acute Myocardial Infarction) registry between January 1995 and April 2011,
436 patients received thrombolysis. Streptokinase was the only lytic agent
used. Multivariate logistic regression was used to determine predictors of
thrombolysis success. 
Results: Thrombolysis success, defined as chest pain relief below 5 in a
scale from 1 to 10 and ST elevation resolution over 50% from baseline, was
obtained in 306 patients (70%). Time to treatment less than 3 hours (p=0.001;
OR= 2.13), smoking (p=0.001, OR=2.1), and inferior location (p=0.009,
OR=1.83) were identified as independent predictors of thrombolysis success.
Inversely, severe heart failure (Killip III and IV classes) were found to be pre-Mortality according to Renal Impairment and CIN
